In a biotech landscape crowded with broad-spectrum solutions, Ceragen is making a bold, surgical bet: stop treating symptoms and attack the root cause of pathogen problems. Their entire digital presence screams focus, but their traction tells a different story.

"With $4.2M in revenue on just $5M raised, Ceragen is capital efficient—but the 288 monthly visits suggest they're building in stealth mode, not chasing web traffic."

Their tech stack reveals a pragmatic, no-frills approach. Squarespace for the site, Tailwind and Bootstrap for styling, and basic security (HSTS, reCAPTCHA). This isn't a flashy, heavy-engineering site—it's a functional brochure. The real R&D is happening in the lab, not on the web server. The lack of a Trustpilot presence or public reviews further confirms this is a B2B play where reputation is built on private partnerships, not public reviews.

• Capital Efficiency: Generating $4.2M revenue with a lean 27-person team.
• Stealth Growth: Virtually zero web presence; growth is likely driven by direct sales and partnerships.
• Focused Leadership: A founder-led team with clear roles in product and lab operations.